Clinical trial

Lamotrigine add-on Therapy for Bipolar Disorder and Cocaine Dependency

NCT00280293 · University of Texas Southwestern Medical Center, Other · Completed

Key facts

NCT number NCT00280293
Title Lamotrigine add-on Therapy for Bipolar Disorder and Cocaine Dependency
Official title A Randomized, Double-blind, Placebo-controlled, Trial of Lamotrigine add-on Therapy in Outpatients With Bipolar Disorder, Depressed or Mixed Phase and Cocaine Dependence
Lead sponsor University of Texas Southwestern Medical Center, Other
Status Completed
Phase Phase 4
Study type Interventional
Conditions Bipolar Disorder, Cocaine Dependence
Intervention type Drug
Interventions Lamotrigine, Placebo
Enrollment 112
Start date Mar 1, 2006
Primary completion Jan 1, 2010
Completion Jan 1, 2010
First posted Jan 20, 2006
Last update posted Sep 26, 2013
Countries United States

At a glance

  • 1–9 Study sites
  • Yes Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies